Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Oncotelic Therapeutics's price to sales ratio was 228.1× on Apr 30, 2024, against 6.8× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 228.1× | +212.5 |
| 2021 | Apr 30, 2021 | 15.6× | −19.0 |
| 2014 | Apr 30, 2014 | 34.6× | +27.9 |
| 2013 | Oct 31, 2013 | 6.7× | – |
See a number that looks wrong?